CRISPR-dependent base editing as a therapeutic strategy for rare monogenic disorders
Rare monogenic disorders are caused by mutations in single genes and have an incidence rate of less than 0.5%. Due to their low prevalence, these diseases often attract limited research and commercial interest, leading to significant unmet medical needs. In a therapeutic landscape where treatments a...
Saved in:
| Main Authors: | Júlia-Jié Cabré-Romans, Raquel Cuella-Martin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Genome Editing |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fgeed.2025.1553590/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishment and rescue of fibroblast cell lines carrying a nonsense mutation of RB1 by CRISPR-based base editing
by: Youngri Jung, et al.
Published: (2025-07-01) -
Genetic Editing with CRISPR Cas9: recent Biomedical and Biotechnological Applications
by: Fabián Andrés Garzón Posse, et al.
Published: (2024-03-01) -
Engineering biotic stress tolerance via CRISPR-Cas mediated genome editing in crop plants
by: Amjad Hussain, et al.
Published: (2024-12-01) -
Editorial: Molecular mechanisms and treatment of monogenic skeletal disorders
by: Chao Xu, et al.
Published: (2025-08-01) -
CRISPR-mediated genome editing of wheat for enhancing disease resistance
by: Joshua Waites, et al.
Published: (2025-02-01)